Sung Lee

Sung Lee is a declared insider at 3 companies; the most frequent names are Cytokinetics Inc, Vir Biotechnology, Inc. and Tango Therapeutics, Inc. Between 27 March 2023 and 29 June 2026, the trades on record add up to 27 filings.

Sales make up the whole of the open-market record (4 sales, €322k). The totals do not cover 2 filings with an undisclosed amount. Outside the open market, there are 11 share grants and 12 option exercises. 2026 to date brings no purchases and 3 sales.

On 29 June 2026 came the latest disclosure, an option exercise in Cytokinetics Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.